FDA’s top drug regulator resigns
Digest more
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, ...
Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...
The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...
The FDA announced it will relax certain rules for approving low-cost versions of some high-priced medications.
The brain drug developer plans to slash R&D expenses by about 60% in the wake of the FDA surprisingly rejecting its rare disease drug Vyglxia.
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...
CT Insider on MSN
CT company recalls pasta sauces sold at Big Y and Stop & Shop due to food poisoning risk, FDA says
Sales and production of the sauces made by First and Last Bakery have been suspended to ensure compliance with regulations, ...
The Trump administration is reportedly finalizing a deal with Eli Lilly and Novo Nordisk that would lower prices on Wegovy, ...
The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback